P

Inventor

GUCKIAN KEVIN M

US22 patents
⚠️ This page may combine multiple inventors who share the name “GUCKIAN KEVIN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BIOGEN MA INC

17 patents
US9186367B2Nov 17, 2015

Bicyclic aryl sphingosine 1-phosphate analogs

BIOGEN MA INC15 citations91
US10166250B2Jan 1, 2019

Bicyclic aryl sphingosine 1-phosphate analogs

BIOGEN MA INC9 citations84
US9827258B2Nov 28, 2017

Bicyclic aryl sphingosine 1-phosphate analogs

BIOGEN MA INC8 citations84
US9572824B2Feb 21, 2017

Bicyclic aryl sphingosine 1-phosphate analogs

BIOGEN MA INC10 citations84
US10034869B2Jul 31, 2018

S1P modulating agents

BIOGEN MA INC2 citations73
US12275728B2Apr 15, 2025

O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors

BIOGEN MA INC0 citations60
US12180205B2Dec 31, 2024

O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors

BIOGEN MA INC0 citations60
US10406144B2Sep 10, 2019

SIP modulating agents

BIOGEN MA INC0 citations52
US10081646B2Sep 25, 2018

Heterobicyclic sphingosine 1-phosphate analogs

BIOGEN MA INC0 citations52
US10017506B2Jul 10, 2018

ATX modulating agents

BIOGEN MA INC0 citations52
US9944666B2Apr 17, 2018

Compounds that are S1P modulating agents and/or ATX modulating agents

BIOGEN MA INC0 citations52
US12565504B2Mar 3, 2026

Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors

BIOGEN MA INC0 citations50
US12522595B2Jan 13, 2026

Bicyclic ether O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors

BIOGEN MA INC0 citations50
US12421224B2Sep 23, 2025

Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors

BIOGEN MA INC0 citations50
US12319679B2Jun 3, 2025

Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors

BIOGEN MA INC0 citations50
US11459324B2Oct 4, 2022

O-glycoprotein-2-acetamido-2-deoxy-3-D-glycopyranosidase inhibitors

BIOGEN MA INC0 citations50
US11427561B2Aug 30, 2022

IRAK4 inhibiting agents

BIOGEN MA INC0 citations49

BIOGEN IDEC INC

2 patents

Caldwell richard d

2 patents

THOMAS JERMAINE

1 patent